Astrazeneca (AZN) Cash from Financing Activities (2009 - 2026)
Astrazeneca's Cash from Financing Activities came in at -$47 million for Q2 2026, compared with $1.28 billion a year earlier.
Powered by 
Analysis
Astrazeneca (AZN) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Astrazeneca reported Cash from Financing Activities of $5.55 billion, down 24.3% year-over-year; for FY2025, it came in at $7.77 billion, up 100.1% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $3.88 billion in FY2024 (-38.2%), $6.28 billion in FY2023 (-8.3%), $6.85 billion in FY2022 and -$5.1 billion in FY2021.
- The Q2 2026 figure represents the lowest quarterly Cash from Financing Activities since Q4 2021.
- Year-over-year, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 120.8%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2025 (growth of 500.0%), and the weakest in Q1 2024 (a decline of 96.1%).
- Business Quant data shows AZN's Cash from Financing Activities at $1.57 billion (Q1 2026), $896 million (Q4 2025) and $3.13 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | -426.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -47.00 Mn |
| Mar 31, 2026 | 1.57 Bn |
| Dec 31, 2025 | 896.00 Mn |
| Sep 30, 2025 | 3.13 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 2.46 Bn |
| Dec 31, 2024 | 1.73 Bn |
| Sep 30, 2024 | 1.87 Bn |
| Jun 30, 2024 | 213.00 Mn |
| Mar 31, 2024 | 73.00 Mn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.89 Bn |
| Jun 30, 2022 | 448.00 Mn |
| Mar 31, 2022 | 3.06 Bn |
| Dec 31, 2021 | -5.60 Bn |
| Sep 30, 2021 | -8.75 Bn |
| Jun 30, 2021 | 656.00 Mn |
| Mar 31, 2021 | 2.49 Bn |
| Dec 31, 2020 | 1.94 Bn |
| Sep 30, 2020 | 1.24 Bn |
API Access
Astrazeneca Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();